| Name | Title | Contact Details |
|---|---|---|
Melissa Ciurlino |
Vice President, Ethics and Compliance Officer, Global Allergan Aesthetics, RandD and OEC Excellence | Profile |
Stephen Lawniczak |
AbbVie Chief Ethics & Compliance Officer | Profile |
Cindy K |
Associate Director, Business Human Resources - Oncology | Profile |
Assil O |
Chief Equity Officer and Vice President People Experience | Profile |
Kari Haley |
HR Systems/HCM ASC Director | Profile |
Cellectis is developing the first of its kind allogeneic approach for CAR-T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients. As a clinical-stage biopharmaceutical company with over 20 years of expertise in gene editing, Cellectis is developing life-changing product candidates utilizing TALEN®, its proprietary gene editing technology, and PulseAgile, its pioneering electroporation system to harness the power of the immune system in order to target and eradicate cancer cells.
DestinationRX is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
We never stop striving for a better future. A true passion for improving patient lives. Medical education - The surgeon is never alone.
Ria Healths at-home program uses technology, anti-craving medication & online coaching to help you reduce or quit drinking. Change your habits today.